90% Effective Dose of Norepinephrine Infusions Under Intensive and Standard Treatment
NCT06151509
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Adverse Effect
Interventions
DRUG:
Alpha-Agonist
DRUG:
α-adrenergic receptor agonist
Sponsor
General Hospital of Ningxia Medical University